Genmab — Juli 2024
-
Genmabs supersællert får udvidet godkendelse i USA https://proinvestor.com/investornyt/1192960/genmabs-supersaellert-far-udvidet-godkendelse-i-usa
-
Nu er del vel, ret beset, Genmabs - ret så trælse - samarbejdspartner , er har fået godkendelsen. Jeg vil meget hellere høre om udvikling af nye tiltag i Genmab internt!
-
Apropos JvdW bestyrelsesarbj. har han haft nok at se til. Han udskifter CEO og CFO i Hookipa. https://ir.hookipapharma.com/news-releases/news-release-details/hookipa-pharma-announces-leadership-changes-intensify-focus-hb
-
Tjaaa - umiddelbart, skulle man jo synes, at han har nok at gøre med Genmab. På den anden side, kan det jo give megen inspiration, at deltage i andre selskaber.
-
Er der nogen af jer der ved, hvorfor Genmab vælger at offentliggøre regnskaber m.v. efter luk på hovednoteringen, men medens den sekundære i US er åben for handel?
-
J&J touts new 'foundational' frontline multiple myeloma treatment as Darzalex Faspro nabs quadruplet FDA nod https://www.fiercepharma.com/pharma/jj-touts-new-foundational-frontline-multiple-myeloma-treatment-darzalex-faspro-nabs
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Month-end today though